Details
Category: Volume 06 Issue 01 January 2018
Hits: 1279

Title: A Comparative Study of Biliary and Serum Lipid Profiles in Patients of Obstructive jaundice due to stones in common bile duct

Authors: MD. Abu Nasar, Tarannum Fatima Subhani, R.R. Sinha

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.144

Abstract

The prevalence of cholesterol gallstones and common bile duct (CBD) stones in India is very high depending on dietary patterns and ethnic background. It is now widely accepted that the primary event in the pathogenesis of cholesterol gallstones is an altered lipid metabolism giving rise to a greater proportion of cholesterol relative to other bile lipids secreted from the liver into bile. The association of cholesterol super saturation of bile with cholesterol gallstones paved the way to a physical-chemical basis for gallstone formation. It however, soon became clear that other factors including nucleation of cholesterol crystal, binding together of these crystals with mucin, and hypo motility of the gall bladder played an equally important roles in gallstone formation.

In the present study bile and serum were collected from 46 choledocholithiasis patients during choledochotomy at the Nalanda Medical College Hospital, Patna, India. Of the 46 bile samples collected, the male to female ratio was 1:6.67 (6men and 40 women. Between 19 and 88 years of age, peak incidence of choledocholithiasis was at age 40.Serum and biliary lipid profile was done by enzymatic methods. Serum lipid profile was done for 19 healthy controls of both sexes aged between 25 and 55 years. Results showed significant elevation in both serum high density lipoprotein (HDL) and low density lipoprotein (LDL) when compared with controls. Biliary cholesterol, HDL and LDL was raised significantly when compared with serum samples. There is correlation between serum and biliary lipid profiles in causing common bile duct (cbd) stones in Indian population. Both serum and biliary HDL consistently showed higher values in Indian patients.

Keywords: HDL: High density lipoproteins LDL: Low density lipoproteins CSI: Cholesterol saturation index LI: Lithogenic index.

References

  1. Nasser E, Issa A, Rajab E, Ali G. Prevalence of Gallstones post-cholecystectomy in diabetic patients. JMJ 2007;7(1);42-4.
  2. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996;26:343-52.
  3. Weiss KM, Ferrell RE, Hanis CL, Styne PN. Genetics and epidemiology of gallbladder disease in New World native peoples. Am J Hum Genet 1984;36:1259-78.
  4. Danzinger RG, Gordon H, Schoenfield LJ, Thistle JL. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972;47:762-6.
  5. Gilat T, Feldman C, Halpern Z, Dan M, Bar-Meir S. An increased familial frequency of gallstones. Gastroenterology 1983;84:242-6.
  6. Jorgensen T. Gallstones in a Danish population: familial occurrence and social factors. J Biosoc Sci 1988;20:111-20.
  7. Kesäniemi YA, Koskenvuo M, Vuoristo M, Miettinen TA. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989;30:1750-6.
  8. Tandon RK . Current development in the pathogenesis of gallstones. Trop Gastroenterol. 1990:11:130-9.
  9. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, Palasciano G. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000;30(4):317-24.
  10. Freeman ML, Prigge WF, Hunninghake DB, Duane WC, Gebhard RL. Intestinal HMGCoA reductase activity is low in hypercholesterolaemic patients and is further decreased with lovastatin therapy. J Lipid Res 1988;29:839-45.
  11. Hoogerbrugge vd Linden N, de Rooy FW, Jansen H, Van Blankenstein M. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hyper cholesterolaemia. Gut 1990;31:348-50.
  12. Nakama T, Furusawa T, Itoh H, Hisadome T. Correlation of cholesterol and bilirubin solubilization in bile salt solution, Gastroenterol Jpn. 1979;14(6):565-72.
  13. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem1974; 20:470-5.
  14. Gambino SR. In: Standard methods of clinical chemistry. Meiter S. Ed., Academic Press. 1965;5:55.
  15. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;20:470-5.
  16. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632-9.
  17. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, et al. The burden of selected digestive diseases in the United States, Gastroenterology 2002;122:1500-11.
  18. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991;20:1-19.
  19. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368(9531):230-9.
  20. Amigo L, Zanlungo S, Mendoza H, Miquel JF, Nervi F. Risk factors and pathogenesis of cholesterol gallstones: state of the Art (Editorial). Eur Rev Med Pharmacol Sci 1999;3(6):241-6.
  21. Avunduk C. Gallstones. In: Manual of Gastroenterology: Diagnosis and Therapy. Edn. 4. Lippincott Williams & Wilkins. 2008;351.
  22. Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM. Plasma Lipid Profiles of Women With Intrahepatic Cholestasis of Pregnancy. Obstet Gynecol 2006;107:106-114.
  23. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut 1991;32:316-20.
  24. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease, The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO), Hepatology 1988;8(4):907-13.
  25. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978;299:1221-7.
  26. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting, Arch Intern Med 1989;149:1750-3.
  27. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian study on epidemiology of cholelithiasis. Hepatology 1997;26:809-18.
  28. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132-140.
  29. Cuevas A, Miquel JF, Reyes MS, Zanlungo S, Nervi F. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr 2004;23:187-96.
  30. Denbesten L, Connor WE, Bell S. The effect of dietary cholesterol on the composition of human bile. Surgery 1973;73:266-73.
  31. Lee DW, Gilmore CJ, Bonorris G, Cohen H, Marks JW, Cho-Sue M, Meiselman MS, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects, Am J Clin Nutr 1985;42:414-20.
  32. Nervi F, Covarrubias C, Bravo P, Velasco N, Ulloa N, Cruz F, Fava M, et al. Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. Gastroenterology 1989;96:825-30.
  33. Andersen E, Hellstrom K. The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 1979;20:1020-7.
  34. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gall stone disease: a case-control study. BMJ (Clin Res Ed) 1984;288:1113-9.
  35. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino, AM, Ceo R, Trevisan M. Diet, physical activity, and gallstones—a population-based, case-control study in southern Italy, Am J Clin Nutr. 1999;69(1):120-6.
  36. Jonnalagadda SS, Trautwein EA, Hayes KC. Dietary fats rich in saturated fatty acids (12:0, 14:0, and 16:0) enhance gallstone formation relative to monounsaturated fat (18:1) in cholesterol-fed hamsters, Foster Biomedical Research Laboratory, Brandeis University, Waltham, Massachusetts 02254, USA, Lipids 1995;30(5):415-24.
  37. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study, Ann Intern Med 2004;141: 514-22.
  38. Honda A, Yoshida T, Tanaka N, Matsuzaki Y, He B, Osuga T, Kobayashi N, et al. Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones. Gastroenterol Jpn 1993;28:406-14.
  39. Tsunoda K, Shirai Y, Hatakeyama K. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology 2004;51:1271-4.
  40. Cavallini A, Messa C, Mangini V, Argese V, Misciagna G, Giorgio I. Serum and bile lipids in young women with radiolucent gallstones, Am J Gastroenterol 1987;82(12): 1279-82.
  41. Aulakh R, Mohan H, Attri AK, Kaur J, Punia RPS. A comparative study of serum lipid profile and gallstone disease. Indian J Pathol Microbiol 2007;50(2):308-12.

Corresponding Author

Dr Tarannum Fatima Subhani

C/O Dr Naseer Ahmad, H.N-168/2, Sector-B,

New Azimabad Colony, Patna (Bihar, India) Pin Code- 800006

Mobile No- 0091-8252375507, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.